Treatment and prognostic factors in acute myeloid leukaemia

被引：29

作者：

Rowe, JM ^{[1
]}

Liesveld, JL ^{[1
]}

机构：

[1] UNIV ROCHESTER, SCH MED & DENT, CLIN SERV, HEMATOL UNIT, ROCHESTER, NY 14642 USA

来源：

BAILLIERES CLINICAL HAEMATOLOGY | 1996年 / 9卷 / 01期

关键词：

D O I：

10.1016/S0950-3536(96)80038-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The treatment of acute myeloid leukaemia (AML) has evolved considerably over the past decade. While induction therapy appears to have been almost standardized, there continues to be an ongoing debate and controversy regarding the best form of post-remission therapy. Furthermore, attempts are being made to identify patients at particular risk of relapse to enable appropriate selection of best induction and post-remission therapies. New concepts include the use of growth factors, immunotherapy and MDR modulation at various stages in the treatment of AML, and all of these will be discussed in this chapter.

引用

页码：87 / 105

页数：19

共 104 条

[61] EFFECT OF GRANULOCYTE COLONY-STIMULATING FACTOR AFTER INTENSIVE INDUCTION THERAPY IN RELAPSED OR REFRACTORY ACUTE-LEUKEMIA [J].

OHNO, R ;

TOMONAGA, M ;

KOBAYASHI, T ;

KANAMARU, A ;

SHIRAKAWA, S ;

MASAOKA, T ;

OMINE, M ;

OH, H ;

NOMURA, T ;

SAKAI, Y ;

HIRANO, M ;

YOKOMAKU, S ;

NAKAYAMA, S ;

YOSHIDA, Y ;

MIURA, AB ;

MORISHIMA, Y ;

DOHY, H ;

NIHO, Y ;

HAMAJIMA, N ;

TAKAKU, F .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (13) :871-877

[62]

OMURA G A, 1982, Cancer, V49, P1530, DOI 10.1002/1097-0142(19820415)49:8<1530::AID-CNCR2820490804>3.0.CO

[63]

2-1

[64] AUTOLOGOUS MARROW TRANSPLANTATION FOR PATIENTS WITH ACUTE MYELOID-LEUKEMIA IN UNTREATED 1ST RELAPSE OR IN 2ND COMPLETE REMISSION [J].

PETERSEN, FB ;

LYNCH, MHE ;

CLIFT, RA ;

APPELBAUM, FR ;

SANDERS, JE ;

BENSINGER, WI ;

BENYUNES, MC ;

DONEY, K ;

FEFER, A ;

MARTIN, P ;

STORB, R ;

ROWLEY, S ;

SULLIVAN, KM ;

WITHERSPOON, R ;

WEIDEN, P ;

THOMAS, ED ;

FISHER, L ;

HANSEN, JA ;

BUCKNER, CD .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (07) :1353-1360

[65]

PETTI MC, 1993, LEUKEMIA, V7, P36

[66]

PHILLIPS GL, 1991, BLOOD, V77, P1429

[67] THE FREQUENCY OF LONG-TERM REMISSION IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA TREATED WITH CONVENTIONAL MAINTENANCE CHEMOTHERAPY - A STUDY OF 760 PATIENTS WITH A MINIMAL FOLLOW-UP TIME OF 6 YEARS [J].

PREISLER, HD ;

ANDERSON, K ;

RAI, K ;

CUTTNER, J ;

YATES, J ;

DUPRE, E ;

HOLLAND, JF .

BRITISH JOURNAL OF HAEMATOLOGY, 1989, 71 (02) :189-194

[68]

Prentice H G, 1994, Prog Clin Biol Res, V389, P239

[69]

RAZA A, 1990, BLOOD, V76, P2191

[70] COMPARISON OF ALLOGENEIC OR AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA IN 1ST REMISSION - A PROSPECTIVE CONTROLLED TRIAL [J].

REIFFERS, J ;

GASPARD, MH ;

MARANINCHI, D ;

MICHALLET, M ;

MARIT, G ;

STOPPA, AM ;

CORRONT, B ;

DAVID, B ;

GASTAUT, JA ;

SOTTO, JJ ;

BROUSTET, A ;

CARCASSONNE, Y ;

HOLLARD, D .

BRITISH JOURNAL OF HAEMATOLOGY, 1989, 72 (01) :57-63

← 2 3 4 5 6 7 8 9 10 11 →